We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
AWM
1176
Avior Wealth Management
Nebraska
$1.93M +$593K +1,112 +41%
VCA
1177
Verdence Capital Advisors
Maryland
$1.93M +$142K +267 +8%
FBC
1178
Fairfield, Bush & Co
Connecticut
$1.93M -$275K -517 -12%
FMII
1179
Farmers & Merchants Investments Inc
Nebraska
$1.93M +$5.86K +11 +0.3%
HI
1180
Horizon Investments
North Carolina
$1.93M +$63.4K +119 +3%
OA
1181
Oak Associates
Ohio
$1.92M +$2.02M +3,791 New
AAS
1182
Ameritas Advisory Services
Nebraska
$1.91M +$1.67M +3,142 +461%
HCM
1183
Highview Capital Management
Illinois
$1.91M -$77.3K -145 -4%
GIM
1184
Groesbeck Investment Management
New Jersey
$1.9M +$53.3K +100 +3%
CSPAM
1185
Cary Street Partners Asset Management
Virginia
$1.9M +$24.5K +46 +1%
GPA
1186
Guerra Pan Advisors
New Jersey
$1.9M -$24.5K -46 -1%
CGL
1187
Clarius Group LLC
Washington
$1.89M -$538K -1,010 -21%
DWT
1188
Dorsey & Whitney Trust
South Dakota
$1.88M -$290K -545 -13%
PHM
1189
Prospect Hill Management
New Jersey
$1.87M
STA
1190
Summit Trail Advisors
New York
$1.86M -$7.46K -14 -0.4%
Voloridge Investment Management
1191
Voloridge Investment Management
Florida
$1.86M -$12.9M -24,171 -87%
LAS
1192
Lloyd Advisory Services
Georgia
$1.85M +$1.95M +3,656 New
NG
1193
Norden Group
Utah
$1.85M +$1.95M +3,656 New
RWM
1194
Ritholtz Wealth Management
New York
$1.85M +$555K +1,041 +40%
Fayez Sarofim & Co
1195
Fayez Sarofim & Co
Texas
$1.84M -$56K -105 -3%
EBWM
1196
Eagle Bluffs Wealth Management
Missouri
$1.84M -$189K -354 -9%
MWM
1197
MBE Wealth Management
Wisconsin
$1.83M
FBT
1198
First Bank & Trust
South Dakota
$1.83M -$103K -194 -5%
OCA
1199
Otter Creek Advisors
Florida
$1.82M -$2.93M -5,500 -60%
CAG
1200
Csenge Advisory Group
Florida
$1.82M -$45.8K -86 -2%

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.